Chronos Archive seal
The Human Record

David Hume

Case HR-EN012 · Modern EHR teaching episode · Draft for review

Review summary

Historical dates
May 7, 1711 – August 25, 1776
Synthetic DOB
1962-05-07
Index visit
2026-05-11 at age 64
Synthetic MRN
HR-EN012-SYN

Teaching objective: Recognize iron deficiency anemia with a change in bowel habit in a man of 64 as possible colorectal cancer; complete colonoscopy, staging CT, and CEA; coordinate preoperative intravenous iron, resection, and three months of adjuvant CAPOX; and begin survivorship surveillance on the CMID schedule with neuropathy and distress checks.

Historical timeline

DateEventClaims
May 7, 1711 (April 26, 1711, Old Style)Born at Edinburgh.CLM-0001
September 1729Beginning of a long illness described in his letter to a physician.CLM-0003
1749His mother had died by the time he went to live at his brother's house.CLM-0002
Spring 1775Struck with a disorder in his bowels.CLM-0004
Early 1776Attending physician describes a hemorrhage in the upper intestines.CLM-0005
April 18, 1776Finished My Own Life.CLM-0004
May 13, 1776Wrote from Bath that his physicians disagreed about the diagnosis.CLM-0006, CLM-0007
August 20, 1776Described his illness as a diarrhoea of two years.CLM-0008
August 25, 1776Died at Edinburgh; no examination after death.CLM-0009, CLM-0010

Evidence claims

D = documented, R = retrospective, S = synthetic.

GradeClaimCertaintySources
D David Hume was born at Edinburgh on April 26, 1711, Old Style (May 7, 1711, in the Gregorian calendar), the second son of Joseph Hume of Ninewells in Berwickshire.
The New Style date is the Old Style date plus eleven days; Britain adopted the Gregorian calendar in 1752.
confirmed Hume D. My Own Life (dated April 18, 1776) supports
Burton JH. Life and Correspondence of David Hume, Volume 1. Edinburgh: William Tait; 1846 supports
D In My Own Life Hume wrote that his father died when he was an infant, leaving him, an elder brother, and a sister in their mother's care, and that his mother had died by the time he went to live at his brother's country house in 1749.
No cause of death is given for either parent in this source.
confirmed Hume D. My Own Life (dated April 18, 1776) supports
D In a letter to a physician written about 1734, Hume described an illness beginning about September 1729, when he was eighteen: loss of his ardour for study, scurvy spots on his fingers, and from about April 1730 a watery mouth, which his physician called 'the disease of the learned'; he was treated with bitters, anti-hysteric pills, a pint of claret a day, and riding, and in 1731 had a ravenous appetite and palpitations.
Contemporary description and label only; no modern diagnosis is inferred.
confirmed Burton JH. Life and Correspondence of David Hume, Volume 1. Edinburgh: William Tait; 1846 supports
D In My Own Life, dated April 18, 1776, Hume wrote that in spring 1775 he was struck with a disorder in his bowels, which at first gave him no alarm but which he came to judge mortal and incurable; he wrote that he had suffered very little pain and that his spirits had never abated.
The documented onset that anchors the synthetic episode. His equanimity is recorded here as sourced history only.
confirmed Hume D. My Own Life (dated April 18, 1776) supports
Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 supports
D In an undated letter written early in 1776, the physician attending Hume reported that he had been declining slowly for several years and more rapidly for about a year, with a sensation of excessive heat chiefly at night, and inferred a hemorrhage in the upper part of the intestines; the letter reports Hume's statement that his mother had the same constitution and died of the same disorder.
Contemporary physician's inference; the family history is Hume's own report as relayed in the letter.
confirmed Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 supports
D Writing from Bath on May 13, 1776, Hume reported that his physicians disagreed about his disorder: one called it a hemorrhage, another a stricture ('spincture') of the colon that would be easy to cure, and a third a bilious complaint.
Documents that no agreed diagnosis was reached in his lifetime.
confirmed Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 supports
D Hume left Edinburgh in late April 1776, passing Morpeth on April 23, and travelled by London to Bath to take the waters; an early improvement had faded by June, and he returned to Edinburgh. confirmed Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 supports
D In a letter of August 20, 1776, Hume described his distemper as a diarrhoea, or disorder in his bowels, which had been gradually undermining him for two years and had been visibly hastening his end within the last six months. confirmed Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 supports
D Hume died at Edinburgh about four in the afternoon on August 25, 1776, aged 65; his physician wrote that he remained perfectly sensible and free from much pain to the last. His body was not opened after death, so the cause of his illness was never established.
Record the death as a fact without graphic detail.
confirmed Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 supports
Qu H, Radcliffe ES. David Hume. Stanford Encyclopedia of Philosophy supports
R Hume's final illness has been interpreted retrospectively as colon cancer; a modern essay calls his death 'probably from colon cancer,' and a reference work describes a terminal abdominal cancer.
Retrospective interpretation without pathology. Spread to the liver is sometimes suggested but was not confirmed in a fetched source and is not asserted.
possible Miller S. The Death of Hume. The Wilson Quarterly supports
Qu H, Radcliffe ES. David Hume. Stanford Encyclopedia of Philosophy supports
Wilkinson J. The last illness of David Hume. Proc R Coll Physicians Edinb. 1988;18(1):72-79. PMID 11621530 context

Modern synthetic problem list

GradeProblemClinical statusVerificationPlacementHistorical claims
S Adenocarcinoma of the sigmoid colon, suspected at presentation and confirmed by colonoscopic biopsy; synthetic modern diagnosis linked to the documented 1775 bowel disorder and its retrospective interpretation as colon cancer active confirmed both_with_link CLM-0004, CLM-0005, CLM-0010
S Iron deficiency anemia from chronic blood loss from the colon tumor active confirmed active CLM-0005
S Hemangioma of the liver, 9 mm, segment VI; incidental finding characterized by MRI, not a metastasis active confirmed active CLM-0010
S Acute viral upper respiratory infection during adjuvant chemotherapy, without fever or neutropenia; resolved resolved confirmed active
S Oxaliplatin-induced sensory peripheral neuropathy, grade 1, fingertips and toe tips, without functional impairment active confirmed active

Synthetic outcome measures

GradeDateMeasureResultCoding
S 2026-05-11 Hemoglobin [Mass/volume] in Blood 10.6 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-05-11 MCV [Entitic mean volume] in Red Blood Cells by Automated count 74 fL (low)
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-05-11 Leukocytes [#/volume] in Blood by Automated count 7.4 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-05-11 Platelets [#/volume] in Blood by Automated count 438 10*3/uL (high)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-05-11 Ferritin [Mass/volume] in Serum or Plasma 9 ng/mL (low)
Reference 30-400 ng/mL
http://loinc.org · 2276-4
S 2026-05-11 Iron saturation [Mass Fraction] in Serum or Plasma 6% (low)
Reference 20-50%
http://loinc.org · 2502-3
S 2026-05-11 Sodium [Moles/volume] in Serum or Plasma 139 mmol/L
Reference 135-145 mmol/L
http://loinc.org · 2951-2
S 2026-05-11 Potassium [Moles/volume] in Serum or Plasma 4.2 mmol/L
Reference 3.5-5.1 mmol/L
http://loinc.org · 2823-3
S 2026-05-11 Creatinine [Mass/volume] in Serum or Plasma 0.94 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-05-11 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 91 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-05-11 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 22 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2026-05-11 Albumin [Mass/volume] in Serum or Plasma 3.8 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-05-11 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-06-01 Carcinoembryonic Ag [Mass/volume] in Serum or Plasma 6.4 ng/mL (high)
Reference <=3 ng/mL
http://loinc.org · 2039-6
S 2026-06-01 Hemoglobin [Mass/volume] in Blood 10.3 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-06-01 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 24 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2026-06-01 Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma 21 U/L
Reference 8-48 U/L
http://loinc.org · 1920-8
S 2026-06-01 Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma 88 U/L
Reference 40-129 U/L
http://loinc.org · 6768-6
S 2026-06-01 Bilirubin.total [Mass/volume] in Serum or Plasma 0.6 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-07-13 Carcinoembryonic Ag [Mass/volume] in Serum or Plasma 2.2 ng/mL
Reference <=3 ng/mL
http://loinc.org · 2039-6
S 2026-07-13 Hemoglobin [Mass/volume] in Blood 12.4 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-07-13 MCV [Entitic mean volume] in Red Blood Cells by Automated count 82 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-07-13 Leukocytes [#/volume] in Blood by Automated count 6.8 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-07-13 Neutrophils [#/volume] in Blood by Automated count 4.1 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 2026-07-13 Platelets [#/volume] in Blood by Automated count 312 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-07-13 Ferritin [Mass/volume] in Serum or Plasma 186 ng/mL
Reference 30-400 ng/mL
http://loinc.org · 2276-4
S 2026-07-13 Iron saturation [Mass Fraction] in Serum or Plasma 24%
Reference 20-50%
http://loinc.org · 2502-3
S 2026-07-13 Creatinine [Mass/volume] in Serum or Plasma 0.96 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-07-13 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 88 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-07-13 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 20 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2026-07-13 Bilirubin.total [Mass/volume] in Serum or Plasma 0.5 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-07-13 Albumin [Mass/volume] in Serum or Plasma 3.9 g/dL
Reference 3.5-5 g/dL
http://loinc.org · 1751-7
S 2026-07-13 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 1 http://loinc.org · 55758-7
S 2026-10-19 Carcinoembryonic Ag [Mass/volume] in Serum or Plasma 1.8 ng/mL
Reference <=3 ng/mL
http://loinc.org · 2039-6
S 2026-10-19 Hemoglobin [Mass/volume] in Blood 12.8 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-10-19 MCV [Entitic mean volume] in Red Blood Cells by Automated count 89 fL
Reference 80-100 fL
http://loinc.org · 787-2
S 2026-10-19 Leukocytes [#/volume] in Blood by Automated count 5.2 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-10-19 Neutrophils [#/volume] in Blood by Automated count 2.9 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 2026-10-19 Platelets [#/volume] in Blood by Automated count 128 10*3/uL (low)
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-10-19 Creatinine [Mass/volume] in Serum or Plasma 0.92 mg/dL
Reference 0.74-1.35 mg/dL
http://loinc.org · 2160-0
S 2026-10-19 Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M 93 mL/min/1.73 m²
Reference >=60 mL/min/1.73 m²
http://loinc.org · 98979-8
S 2026-10-19 Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma 31 U/L
Reference 7-55 U/L
http://loinc.org · 1742-6
S 2026-10-19 Bilirubin.total [Mass/volume] in Serum or Plasma 0.7 mg/dL
Reference 0.1-1.2 mg/dL
http://loinc.org · 1975-2
S 2026-10-19 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-09-08 Leukocytes [#/volume] in Blood by Automated count 4.6 10*3/uL
Reference 4-11 10*3/uL
http://loinc.org · 6690-2
S 2026-09-08 Neutrophils [#/volume] in Blood by Automated count 2.4 10*3/uL
Reference 1.5-7.7 10*3/uL
http://loinc.org · 751-8
S 2026-09-08 Hemoglobin [Mass/volume] in Blood 12.1 g/dL (low)
Reference 13.2-16.6 g/dL
http://loinc.org · 718-7
S 2026-09-08 Platelets [#/volume] in Blood by Automated count 156 10*3/uL
Reference 150-400 10*3/uL
http://loinc.org · 777-3
S 2026-10-28 Cholesterol [Mass/volume] in Serum or Plasma 196 mg/dL
Reference <=199 mg/dL
http://loinc.org · 2093-3
S 2026-10-28 Cholesterol in HDL [Mass/volume] in Serum or Plasma 52 mg/dL
Reference >=40 mg/dL
http://loinc.org · 2085-9
S 2026-10-28 Cholesterol in LDL [Mass/volume] in Serum or Plasma by calculation 118 mg/dL (high)
Reference <=99 mg/dL
http://loinc.org · 13457-7
S 2026-10-28 Hemoglobin A1c/Hemoglobin.total in Blood 5.5%
Reference <=5.6%
http://loinc.org · 4548-4
S 2026-10-28 Patient Health Questionnaire 2 item (PHQ-2) total score [Reported] 0 http://loinc.org · 55758-7
S 2026-10-28 Total score [AUDIT-C] 4 http://loinc.org · 75626-2

Synthetic vital signs

DateMeasureResultLOINCGrade
2026-05-11Body height178 cm8302-2S
2026-05-11Body weight88 kg29463-7S
2026-05-11Body mass index (BMI) [Ratio]27.8 kg/m239156-5S
2026-05-11Systolic blood pressure132 mm[Hg]8480-6S
2026-05-11Diastolic blood pressure80 mm[Hg]8462-4S
2026-05-11Heart rate92 /min8867-4S
2026-05-11Respiratory rate16 /min9279-1S
2026-05-11Body temperature36.8 Cel8310-5S
2026-05-11Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-06-01Body height178 cm8302-2S
2026-06-01Body weight87.2 kg29463-7S
2026-06-01Body mass index (BMI) [Ratio]27.5 kg/m239156-5S
2026-06-01Systolic blood pressure130 mm[Hg]8480-6S
2026-06-01Diastolic blood pressure78 mm[Hg]8462-4S
2026-06-01Heart rate88 /min8867-4S
2026-06-01Respiratory rate16 /min9279-1S
2026-06-01Body temperature36.7 Cel8310-5S
2026-06-01Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-07-13Body height178 cm8302-2S
2026-07-13Body weight82.5 kg29463-7S
2026-07-13Body mass index (BMI) [Ratio]26 kg/m239156-5S
2026-07-13Systolic blood pressure124 mm[Hg]8480-6S
2026-07-13Diastolic blood pressure76 mm[Hg]8462-4S
2026-07-13Heart rate78 /min8867-4S
2026-07-13Respiratory rate16 /min9279-1S
2026-07-13Body temperature36.6 Cel8310-5S
2026-07-13Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S
2026-10-19Body height178 cm8302-2S
2026-10-19Body weight81 kg29463-7S
2026-10-19Body mass index (BMI) [Ratio]25.6 kg/m239156-5S
2026-10-19Systolic blood pressure122 mm[Hg]8480-6S
2026-10-19Diastolic blood pressure74 mm[Hg]8462-4S
2026-10-19Heart rate76 /min8867-4S
2026-10-19Respiratory rate14 /min9279-1S
2026-10-19Body temperature36.6 Cel8310-5S
2026-10-19Oxygen saturation in Arterial blood by Pulse oximetry99 %59408-5S
2026-09-08Body height178 cm8302-2S
2026-09-08Body weight81.6 kg29463-7S
2026-09-08Body mass index (BMI) [Ratio]25.8 kg/m239156-5S
2026-09-08Systolic blood pressure118 mm[Hg]8480-6S
2026-09-08Diastolic blood pressure72 mm[Hg]8462-4S
2026-09-08Heart rate84 /min8867-4S
2026-09-08Respiratory rate16 /min9279-1S
2026-09-08Body temperature37.3 Cel8310-5S
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry97 %59408-5S
2026-10-28Body height178 cm8302-2S
2026-10-28Body weight81.4 kg29463-7S
2026-10-28Body mass index (BMI) [Ratio]25.7 kg/m239156-5S
2026-10-28Systolic blood pressure122 mm[Hg]8480-6S
2026-10-28Diastolic blood pressure74 mm[Hg]8462-4S
2026-10-28Heart rate72 /min8867-4S
2026-10-28Respiratory rate14 /min9279-1S
2026-10-28Body temperature36.6 Cel8310-5S
2026-10-28Oxygen saturation in Arterial blood by Pulse oximetry98 %59408-5S

Social, functional, and mental status

Social history

Functional status

Mental status

Allergies and medications

Allergies

Medications

Procedures and immunizations

Procedures

Immunizations

Past medical history

True biography with historical dates; not part of the synthetic care timeline.

Family history

Care-plan goals

GoalTarget dateStatusOutcome
Complete diagnosis, staging, and curative resection within six weeks of presentation2026-07-13completedColonoscopy in eight days, staging complete in three and a half weeks, colectomy at five weeks
Replete iron stores before surgery and recover hemoglobin by the postoperative review2026-07-13completedFerritin 186 ng/mL and hemoglobin 12.4 g/dL four weeks after surgery, up from 9 ng/mL and 10.6 g/dL
Complete three months of adjuvant CAPOX with neuropathy no worse than grade 12026-10-19completedFour cycles completed on schedule; grade 1 sensory neuropathy
Start survivorship surveillance with a written survivorship care plan2026-10-19completedSurvivorship care plan given; CEA 1.8 ng/mL; CT and colonoscopy dates set

Interventions

InterventionStatusGuideline
Colonoscopy with biopsy, CT of the chest, abdomen, and pelvis, and baseline CEA for iron deficiency anemia with rectal bleeding in a man of 64completedGL-AGA-IDA-2020, GL-NCCN-COLON-2025, GL-CMID-2026
Medical oncology consultation to review staging, the indeterminate liver lesion, the order of treatment, and adjuvant therapycompletedGL-NCCN-COLON-2025
Intravenous ferric carboxymaltose before surgery to correct iron deficiency anemia, with ferritin and blood count rechecked six to eight weeks latercompletedGL-AGA-IDA-2020, GL-CMID-2026
Laparoscopic sigmoid colectomy with lymph node dissection by the colorectal surgery teamcompletedGL-NCCN-COLON-2025
Three months (four cycles) of adjuvant CAPOX for low-risk stage III disease, after DPYD genotyping, with neuropathy, blood count, and diarrhea checks at every visitcompletedGL-IDEA-2018, GL-NCCN-COLON-2025, GL-CMID-2026
Survivorship surveillance: history, examination, and CEA every 3 to 6 months for 2 years, then every 6 months to 5 years; CT of the chest, abdomen, and pelvis every 6 to 12 months for 5 years; colonoscopy one year after resectioncompletedGL-CMID-2026, GL-ASCRS-2021, GL-ACS-CRC-2015
Distress and depression screening at each visit, at least 150 minutes of activity a week, alcohol at or below one drink a day, and a written survivorship care plancompletedGL-ACS-CRC-2015, GL-CMID-2026

Planned encounters

Supporting documents

C-CDA note documents

Each link opens a readable copy; the XML beside it is the exchange file.

Sources

IDSourcePublisherType
SRC-0001 Hume D. My Own Life (dated April 18, 1776) Hume Texts Online primary
SRC-0002 Burton JH. Life and Correspondence of David Hume, Volume 1. Edinburgh: William Tait; 1846 Project Gutenberg (eBook 42843) biography
SRC-0003 Burton JH. Life and Correspondence of David Hume, Volume 2. Edinburgh: William Tait; 1846 Project Gutenberg (eBook 42844) biography
SRC-0004 Qu H, Radcliffe ES. David Hume. Stanford Encyclopedia of Philosophy Stanford University scholarly
SRC-0005 Miller S. The Death of Hume. The Wilson Quarterly The Wilson Quarterly other
SRC-0006 Wilkinson J. The last illness of David Hume. Proc R Coll Physicians Edinb. 1988;18(1):72-79. PMID 11621530 PubMed scholarly
SRC-0007 HISTMED Master Roster v3 The Human Record project other

Review status

ReviewStatusNotes
schema validationnot_startedRun scripts/build.ps1 -Conformance.
clinical reviewnot_startedAwaiting clinician review; check the CAPOX duration choice, the liver lesion work-up, and the surveillance schedule.
provenance reviewnot_startedMy Own Life (Hume Texts Online), the 1846 Burton biography (Project Gutenberg), the Stanford Encyclopedia entry, and a magazine essay logged; the 1988 article on his last illness was not read, and liver spread is not asserted.
safe messaging reviewnot_startedNo behavioral-health diagnosis; the youthful illness is reported with its contemporary label and flagged sensitive; death recorded without graphic detail.

Comments and corrections

Sign in with GitHub to comment on this record. To report a specific error, ideally with a source, use the feedback form; each report becomes a tracked issue.

Comments appear on the online version of this page.